Table 2.
Characteristics of the 100 most-cited studies about Midazolam.
| Characteristics | Number of Papers | Number of Citations in WoS-CC a | Citation Ratio b |
|---|---|---|---|
| Publication period | |||
| 1981–1991 | 8 | 4001 | 500, 13 |
| 1992–2002 | 52 | 22,125 | 425, 48 |
| 2003–2013 | 39 | 16,308 | 418, 15 |
| 2014–2016 | 1 | 476 | 476, 00 |
| Journal (Impact factor c) | |||
| Clinical Pharmacology & Therapeutics (7.051) | 10 | 3380 | 338, 00 |
| Anesthesiology (9.198) | 7 | 3219 | 459, 86 |
| New England Journal of Medicine (176.082) | 6 | 3747 | 624, 50 |
| Drug Metabolism and Disposition (3.579) | 6 | 2061 | 343, 50 |
| Clinical Pharmacokinetics (5.577) | 5 | 2265 | 453, 00 |
| Molecular Pharmacology (4.058) | 5 | 1909 | 381, 80 |
| Lancet (202.731) | 5 | 1683 | 336, 60 |
| Drugs (11.431) | 4 | 1429 | 357, 25 |
| Jama-Journal of the American Medical Association (157.375) | 4 | 2034 | 508, 50 |
| Gastrointestinal Endoscopy (10.396) | 3 | 1004 | 334, 67 |
| Critical Care Medicine (9296) | 2 | 1428 | 714, 00 |
| Journal of Pharmacology and Experimental Therapeutics (4404) | 2 | 951 | 475, 50 |
| British Journal of Clinical Pharmacology (3716) | 2 | 825 | 412, 5 |
| Gut (31,795) | 2 | 757 | 378, 5 |
| Pharmacogenetics (7221) d | 2 | 682 | 341 |
| Biochemical Pharmacology (6100) | 2 | 666 | 333 |
| Other journals with only one article | 33 | 1487 | 450, 60 |
| Experimental design | |||
| Non-systematic review | 21 | 7898 | 376, 09 |
| Cohort | 14 | 6261 | 447, 21 |
| Randomized clinical trial | 13 | 7148 | 549, 84 |
| Non-randomized clinical trial | 13 | 5154 | 396, 46 |
| In-vitro study | 10 | 4156 | 415, 60 |
| Clinical report | 5 | 1585 | 317, 00 |
| In vivo study | 9 | 4831 | 536, 77 |
| Guideline | 7 | 3111 | 444, 4 |
| Systematic review | 5 | 1750 | 350, 00 |
| Case report | 2 | 696 | 348, 00 |
| Cross-sectional | 1 | 320 | 320, 00 |
| Number of authors | |||
| 1–2 | 13 | 4852 | 373, 23 |
| 3–4 | 24 | 11,365 | 473, 54 |
| 5–6 | 20 | 7609 | 380, 45 |
| >6 | 44 | 19,084 | 433, 73 |
a WoS-CC: Web of Science Core Collection; b Citation ratio: number of citations per number of articles; c Impact factor (2021–2022 years) retrieved on https://jcr.clarivate.com/jcr/home on 17 November 2022; d This journal title was changed; thus, it was considered the journal’s impact factor from the previous year with the original title and ISSN (2006–2022 years).